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ABSTRACT

Sharma, Amit. Ph.D., Biomedical Sciences Program, Wright State University, 2009.
The in vitro Interactions between Tubulin and HIV-1 Rev require Rev’s Multimerization
and Arginine Rich Motifs.

Rev is a 13 kDa regulatory HIV protein essential for viral replication. It transactivates expression of late viral proteins by multimerizing onto target mRNA and
promoting their export into the cytoplasm. During attempts to find the solution conditions
needed to study Rev structure, Watts et al. (2000) discovered that Rev depolymerizes
microtubules (MTs) in vitro through the formation of ringed tubulin intermediates called
Rev-tubulin toroids (RTTs). Rev interactions with MTs are specific and are thought to
mimic the mechanism of Kinesin-13 proteins, themselves potent MT depolymerases that
regulate the assembly of the mitotic spindle. If Rev and Kinesin-13 proteins share a
common mechanism, then Rev mediated MT depolymerization and RTT formation will
require Rev multimerization and its arginine-rich motif (ARM).
If Rev multimerization is essential, then multimerization defective mutants should
not depolymerize MTs and form RTTs.

To test this hypothesis, a combination of

sedimentation, gel filtration and visual assays were used to compare the activities of wildtype Rev with the multimerization defective mutant Rev M4 (M4). Both wild-type Rev
and M4 are able to bind tubulin heterodimers and form high molecular complexes.
However, these complexes are not RTTs. M4 also binds GMPCPP-stabilized MTs but
unlike wild-type Rev, it neither depolymerizes MTs nor forms RTTs. These data show
that Rev multimerization is important for MT depolymerization although it is unclear
whether it is involved in targeting Rev to MT ends or provides the force required for
iv

depolymerization. Because M4 promotes MT bundling, this mutation is concluded to
subtly affect Rev tertiary structure such that the relative orientation of Rev monomers
within a multimer is altered in a manner that allows MT cross-linking.
These same assays were also used to test the hypothesis that the ARM is also
important for Rev-tubulin interactions. In this instance, the activities of wild-type Rev
were compared to the M6 mutant (M6), a well-characterized substitution-deletion mutant
in the ARM predicted to perturb binding, depolymerization and RTT formation. The M6
mutation affects RTT formation when mixed with tubulin heterodimers, reducing both
ring size and the amount of complexes that can be sedimented. In addition, M6 is unable
to depolymerize GMPCPP-stabilized MTs through an apparent inability to bind MT.
Results presented here suggest Rev possesses only a single MT binding motif present in
the ARM. Some residues in this region are critical for binding MT ends where
depolymerization occurs. These conclusions are also consistent with the hypothesis that
Rev interacts with MTs by a mechanism shared with Kinesin-13 proteins, themselves
potent cellular MT depolymerases.
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INTRODUCTION
Human Immunodeficiency Virus-1 (HIV-1) is a causative agent of Acquired
Immune Deficiency Syndrome or AIDS (Malim and Pollard, 1998; Hope et al.,
2001). Millions of people die of AIDS every year. Although the current therapeutic
strategy slows the intensity of AIDS infection there is still no known cure for AIDS.
Consequently, research aimed at understanding the regulation of infection and
identifying novel HIV targets is important. Rev is such a target.
Rev is a 116 amino acid, arginine-rich protein essential for replication of the
HIV (Pollard and Malim, 1998). It activates late viral gene expression by promoting
nuclear export of under-spliced viral mRNAs normally retained and degraded in the
nucleus (Figure 1) (Malim and Cullen, 1989a; Malim et al., 1991). Rev has an
arginine-rich motif (ARM, residues 34-62) that recognizes these RNAs by binding to
a 351-nucleotide, stem loop structure present within an intron called the Rev
Response Element (RRE) (Figure 2). Mutations in the ARM inhibits expression of
late viral genes by inhibiting RRE binding as measured by functional assays
monitoring expression of late viral gene products such as gag and env and assays
monitoring RRE binding, e.g., gel retardation assays and surface plasmon resonance
(Malim et al., 1991, Pollard and Malim, 1998; Van Ryk and Venkatesan, 1999).
Amino acid substitutions and/or deletions of clustered arginine residues in the ARM,
amino acids 38-39 and 41-44 (e.g., M5 and M6 mutations, respectively), profoundly
limit Rev binding to RRE (Malim et al., 1989b; Hammerschmidt et al., 1994; Pollard
and Malim, 1998; Brice et al., 1999) (Table 1). Additional RNA footprinting
experiments confirm arginines 38, 39, 50, and 66 are important for binding the RRE
(Jensen et al., 1995).
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Figure 1: The Biological Function of Rev. A) HIV-1 Rev transcribes into
completely spliced and RRE containing incompletely spliced transcripts. B)
Incompletely spliced transcripts are not transported into the cytoplasm and are
degraded. C) Completely spliced transcripts are transported to the cytoplasm and are
translated into Rev, Tat and Nef. D) Translated Rev is transported to the nucleus by
binding Importin β. E, F) Rev binds and multimerizes on to RRE. G) Multimerization
stimulates Crm-1 binding to Rev’s NES. This complex is stabilized by Ran-GTP
binding and enables export of Rev-RRE complexes. RRE containing mRNAs are then
translated into the structural proteins (Gag, Env, Pol, Vif, Vpr) of the virus.

2
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Figure 2: Domain Structure of Rev. A) The domain structure of Rev showing the
multimerization motif-1 residing in helix-1, a poly-proline loop, and the ARM and
multimerization motif-2 (mult.2) present in helix-2. This figure also shows the
locations of the NES and the M4 and M6 mutations. B) Shows the sequence similarity
shared between Rev and the motor domain of MCAK. Residues marked in red are
identical and those marked in blue are conserved substitutions.
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A.

Rev M4
YSNDDL
23,24,26

Rev M6
RRRRDL
41-44

B.
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Table 1: Summary of mutants used in this study. The table shows the mutants of
Rev and their functional properties (Malim and Cullen, 1991).
Rev Mutant

Mutation

Multimerization

RRE
Binding

Rev M4

YSN(23,25,26)

-

+

DDL
Rev M5

RR(38,39) DL

+

-

Rev M6

RRRR(41-44) DL

+

-

Rev M7

SIS(54-56)  I

-

+
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The RRE consist of a series of intramolecular double stranded RNA stems and single
stranded loops found only within the 3’ introns of viral RNAs (Daly et al., 1989;
Malim et al., 1989; Mann et al., 1994; Malim and Pollard, 1998). Rev binds one such
stem-loop structure called SLIIB with ≈1 nM affinity (Daly et al., 1989; Malim et al.,
1989; Mann et al., 1994; Malim and Pollard, 1998). Specifically, it binds the stem of
SLIIB that forms a distorted helix due to non-Watson-Crick purine-purine base
pairing (G47-A73 and G4-G71) (Bartel et al., 1991; Malim and Polard, 1998). Initial
binding of a Rev monomer is mediated by nonspecific electrostatic interactions
between arginine residues of the ARM and negatively charged phosphate backbone of
RRE as determined by gel retardation and NMR (Daly et al., 1993; Battiste et al.,
1996; Belasco et al., 1996; Van Ryk and Venkatesan, 1999).
Rev binding is insufficient to stimulate export of RRE-containing transcripts;
however, binding the SLIIB site stimulates partially cooperative binding of four
additional Rev monomers (Malim et al., 1989; Daly et al., 1993; Battiste et al., 1996;
Belasco et al., 1996; Van Ryk and Venkatesan, 1999). Multimerization then
stimulates binding of the nuclear export factor Crm1 (also called Exportin) that binds
a nuclear export sequence (NES) present towards the Rev C-terminus (Fornerod et al.,
1997; Fukuda et al., 1997) (Figure 1). This transport complex, stabilized by the
binding of the Ras-like nuclear GTPase Ran bound to GTP (Fukuda et al., 1997), is
exported into the cytoplasm via nuclear pore complexes through interactions with
Nup214 and Nup98 (Fornerod et al., 1997; Zolotukhin and Felber 1999).
Rev Structure
To better understand the mechanism of Rev structure and facilitate
development of antiviral therapies that target Rev function, many labs have attempted
to determine Rev’s tertiary structure. The structure is not completely known largely
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due to Rev’s tendency to aggregate and precipitate precluding structural studies
(Heaphy et al., 1991; Wingfield et al., 1991; Watts et al., 1998). Purified Rev protein
polymerizes into filaments 8 nm in diameter when incubated with RRE at 40-160
µg/mL (Wingfield et al., 1991). At 0°C in the absence of RRE, Rev polymerizes into
hollow filaments 20 nm in diameter with a 5-7 nm diameter axial channel, as viewed
by standard TEM (Heaphy et al., 1991; Wingfield et al., 1991). Higher resolution
STEM analyses show Rev filaments are a six-start helix with 31 dimers in two turns
(Watts et al., 1998). Within the filaments, the Rev dimer has a diameter of 3.2 nm and
a height of 2.2 nm. The outer and inner filament diameters were approximately 14.8
nm and 10.4 nm. The outside of the filament appears smooth whereas the inner
surface has extrusions resembling a ‘top hat.’ (Watts et al., 1998).
Computer modeling and structural studies that include circular dichroism (CD)
and solid-state NMR studies reveal the N-terminal half of unliganded Rev assumes a
helix-loop-helix structure (amino acids 9-24, 25-33, and 34-62, respectively) with
ARM residing in the second helix (residues 34-62) (Auer et al., 1994; Blanco et al.,
2001) (Figure 2). CD analyses of two C-terminal deletion mutants of Rev, RevΔ68112 and RevΔ92-112, show that Rev contains 46-49 residues in α-helical
conformation in the N-terminus (Auer et al., 1994). Deletion of amino acids 8-26
from Rev causes significant reduction in helicity and also inhibits Rev’s ability to
distinguish between RRE and non-specific RNA by 50-fold (Auer et al., 1994).
Conversely residues 75-93 are 40% β-sheet and less than 20% α-helical in nature.
Using Raman spectroscopy, the N-terminus of Rev was found to be α-helical with the
helices oriented in alignment with the longitudinal filament axis (Watts et al., 1998).
Using solid state NMR, Blanco et al. (2001) found backbone dihedral angles between
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residues Leu13 and Val16 and residues Arg39, 42, 43, and 44 are consistent with the
presence of α-helixes.
Havlin et al. (2007) using transmission electron microscopy, atomic force
microscopy and solid state NMR examined the secondary structure of Rev when it is
bound to 45 bp of SLIIB. Intriguingly, although the morphology of Rev filaments
change when it is bound to the RRE (Wingfield et al., 1991; Havlin et al., 2007), the
tertiary structure of Rev does not change detectibly (Havlin et al., 2007).
Structural basis of Rev-RRE interactions
The first glimpse of Rev-RRE structure came when Battiste et al. (1996) used
solution NMR to examine the complex formed between residues 34-50 of Rev and
SLIIB. Their analyses confirm these amino acids assume a helical conformation. They
showed that Asn40 and Arg44 interact with the nucleotides U45, G46, G47, and A73
in the major groove of the RRE. Arginines at positions 38, 41-43, 46 and 48 also
make hydrogen bonds and/or electrostatic interactions with the phosphate backbone
of the RRE. Thr34 that forms hydrogen bonds with G47 further stabilizes these
interactions. Arginines 46, 48 and 50 appear to make van der Waal and electrostatic
contacts that orient the C-terminal helix in the major groove of the RRE (Battiste et
al., 1996).
Various groups have conducted mutational analyses and studied the role of
ARM in Rev-RRE interactions. For example, Belasco et al. (1996) created an
expression vector where lacZ coding sequences were fused to an RRE such that
expression of β-galactosidase was dependent upon Rev function through RRE. By
placing point mutations in the RRE-LacZ or Rev expression constructs, they were
able to identify nucleotides and amino acids important for Rev function, respectively.
They proposed Rev makes multiple contacts with the RRE. Gln36, Gln51, Asn40,

9

Glu47 of ARM are buried in the major groove of the SLIIB. Asn40 contacts the
SLIIB, and Glu47 and Gln51 of ARM lie close to the phosphodiester backbone of the
SLIIB. The series of arginines (34, 35, 38, 39, and 44) were postulated to be
accessible for direct interaction with the RNA.
Mutating individual arginines in the ARM does not affect Rev’s ability to bind
RRE or localize in the nucleus suggesting that deletion of four arginines in the M6
may create a change in the conformation of ARM that prevents it from binding the
RRE (Hammerschmid et al., 1994) (Table 1). Alternatively, the deletion of these four
arginines as a whole may create a critical loss of electrostatic interactions with
phosphate backbone of RRE as these residues form a part of residues that establish
electrostatic contact with the RRE backbone as proposed by Battiste et al. (1996).
The ARM also contains the nuclear localization sequences (NLS) (Malim and
Pollard, 1998; Hope, T.J., 1999). The NLS interacts with importin β that targets Rev
to the nucleus (Truant and Cullen, 1999). The presence of NLS along with the Cterminal NES confers Rev the ability to shuttle in and out of nucleus. Because the
RRE and importin β binding sites are overlapping, Rev bound to RRE can only
exported. Rev cannot be imported into the nucleus until the RRE dissociates thus
preventing the re-import of RRE mRNA back in the nucleus. Whereas most ARM
mutations affect both import and RRE binding, mutating Trp45 affects import and not
RRE binding (Hammerschmid et al., 1994).
Rev multimerization
Many labs have found a correlation between the extent of multimerization on
the RRE as detected by EMSA and the extent that RRE-containing transcripts are
translated (Malim et al., 1989, Cook et al, 1991; Daly et al, 1993). Earliest evidence
of Rev multimerization were obtained by Malim et al. (1989) who identified
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mutations that inhibited Rev function without inhibiting RRE binding. One of these
harbored mutation in the NES (Rev M10). EMSA’s revealed the other two mutants,
M4 and M7, were unable to form multimeric structures on the RRE. They cotransfected Tat expression vector along with wild-type Rev, M4, M7 and M10 in COS
cells. They observed Tat expressed as a truncated 72 amino acid protein in the
presence of wild-type Rev, showing that wild-type Rev was exporting partially
spliced Tat mRNA to the cytoplasm. They however observed expression of a fulllength 86 amino acid Tat protein in the presence of M4, M7 and M10 showing they
are unable to export unspliced RNAs. Subsequent proviral rescue experiments found
that wild-type Rev and not M4, M7 and M10 was able to rescue Rev deficient HIV
replication in COS cells, further suggesting the importance of mutated residues in
Rev’s function (Malim et al., 1989).
Subsequent

mutational

analyses

refined

the

requirement

of

two

multimerization motifs to residues 12-34 (multimerization motif-1) and residues 5163 (multimerization motif-2, Figure 2) (Malim et al., 1989, Auer et al., 1994; Thomas
et al., 1997). Both are rich in hydrophobic residues and are a part of the N-terminal
helix-loop-helix domain (Figure 2) (Auer et al., 1994, Thomas et al., 1998, Blanco et
al., 2001). Thomas et al. (1998) transfected a Rev-dependent expression plasmid into
cells expressing Rev to measure the ability of different multimerization mutants to
trans-activate expression of a reporter gene. This reporter plasmid encodes gene for
chloramphenicol acetyltransferase (CAT) fused to the RRE and is positioned within
an intron. In the presence of Rev activity, the CAT-RRE transcript will be exported
before the CAT coding sequences are spliced out. Using this strategy they found that
amino acids Ala15, Val16, Leu18, Ile19, and Leu22 in multimerization motif-I and
residues Ile52, Ile59, and Leu60 in multimerization motif-II are critical for Rev
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function. They predicted that the two helices bind each other and residues 12-23 in
helix-1 and Ile52, 55 and 59 in helix-2 form a hydrophobic patch creating a site able
to bind a second Rev monomoer (Thomas et al., 1997). This model is supported by
Jensen et al. (1997). They digested Rev with different proteases and used radiolabeled
monoclonal antibodies with defined binding sites to map antigenic sites. By
comparing protein footprints, they showed that Rev N- and C-termini must lie close to
each other.
Although many mutants that inhibit multimerization on the RRE have been
identified, two mutations have be extensively studied: M4 and M7 (Table 1; Malim et
al., 1989, Daly et al., 1995; Thomas et al., 1998; Brice et al., 1999). Malim et al.
(1991) compared the ability of multimerization mutants M4 and M7 with wild-type
Rev to bind radiolabelled RRE. The results of EMSA’s demonstrated that M4 and M7
were unable to form the characteristic high molecular weight complexes normally
formed by wild-type Rev suggesting that M4 and M7 are deficient in multimerization.
Brice et al. (1999) attributed the deficiency of Rev M7 in multimerization to
significant structural disruptions introduced due to double deletions. M4 was found to
be defective in forming higher order multimers due to localized structural changes
(Brice et al., 1999). Daly et al. (1993) demonstrated that Rev-RRE complex consists
of at least 2-8 Rev molecules at equilibrium. Moreover, complexes of two or more
Rev monomers dissociate from RRE less readily than a single bound monomer
suggesting that binding of two or more Rev molecules stabilizes Rev-RRE
complexes. These results are confirmed by findings of Charpentier et al. (1997) who
used dimethyl sulfate (DMS) to study Rev binding sites. DMS methylates the
nitrogen bases of RNA molecules. In turn, methylation can be detected by primer
extension during PCR. Methylation is prevented by protein bound to RNA and thus
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can be used to detect the region in RRE where Rev binds. Peterson and Feigon (1996)
have demonstrated that binding of 28 amino acids of ARM causes the change in
conformation of backbone of the high-affinity binding site in RRE. This was
confirmed by the findings of Charpentier et al. (1997) who found that binding by two
Rev monomers induces a conformation change in RRE that facilitates Rev
oligomerization in vivo.
Belasco et al. (2001) used a different strategy to investigate multimerization.
Two Rev binding sites were introduced upstream of the ribosome binding site (RBS)
of lacZ reporter containing the single copy of wild-type RRE SLIIB. The second of
the two Rev binding sites, adjacent to the RBS was mutated in a way that it could not
bind Rev. The logic of this design is that if Rev binds the Rev binding site upstream
and mutimerizes, it will interfere with the binding of ribosome to the reporter mRNA
and prevent its translation. Using this strategy, they found residues Val16, Leu18,
Ile19, and Leu22 and residues Arg48, Gln50, Ile52, Ile55, Ile59, and Leu60 are
important for Rev multimerzation on RRE.
Van Ryk and Venkatesan (1999) used SPR to measure Rev-RRE interactions.
RRE was adhered to the sensor chip and Rev flowed over the chip. Through the use of
different length of RRE and different titrations of Rev, their results demonstrated that
Rev-RRE binding was partially cooperative and that multimerization was not a
prerequisite for binding. In contrast to the findings of Daly et al. (1993), Van Ryk and
Venkatesan (1999) also demonstrated that the C-terminus was not required for
multimerization. Deletion of residues 87-116 did not affect the binding to the
truncated form of RRE (containing the high affinity SLIIB) and bound with same
affinity as wild-type Rev. Further, Daugherty et al. (2008) have characterized an
additional site stem IA on RRE where oligomerization is inhibited by mutations
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R41A, R42A and W45A. They summarized that Rev uses a combination of binding
modes (binding to Stem IIB, Stem IA) to bind RRE.
In an effort to show the importance of multimerization of Rev in vivo, Madore
et al. (1994) developed a reporter assay similar to two-hybrid system where CAT
expression is dependent upon Rev oligomerization. The reporter assay consisted of a
CAT indicator gene fused to high affinity Rev binding site-SLIIB. Their results
demonstrated that Rev multimerization occurs in vivo. Both the M4 and M7 mutations
inhibited CAT expression although to different extents. M4 stimulated CAT
expression that was only 40% of wild-type Rev levels, M7 retained only 10% ability.
Both mutants were concluded to be multimerization deficient.
Jain and Bellasco (2001) were able to differentiate between three classes of
mutants based on their varying ability to multimerize on RRE in gel retardation
assays. Class one mutants bind the RRE as monomers but are defective in forming
dimers and higher order multimers. For example, mutating amino acids 18 or 55 did
not affect the Kd of the Rev monomer to bind the RRE but reduced the affinity for
dimer binding 10-fold. Class two mutants readily form dimers but show reduced
higher order multimerization. Class three mutants show defects in all stages of RRE
binding which were concluded to be structurally defective. Trikha et al. (2005) used a
reporter construct (HIV envelope derived reporter under CMV early promoter) and
demonstrated that trimerization defective mutants (class two mutants) (L12E, V16D,
L60R; Belasco et al., 2001) were deficient in nuclear export of reporter construct
showing multimerization is essential for nuclear export in vivo.
Daelmans et al., (2004) used FRET and FRAP to show Rev multimerization
occurs in both the cytoplasm and nucleus. They observed FRET interactions between
cytoplasmic mutants fused to GFP and BFP and observed FRET in cytoplasm. They
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also observed localization of Rev M5-GFP in the nucleus when expressed with wildtype Rev-BFP construct confirming Rev multimerization in vivo and that ability to
multimerize does not rely on presence of ARM.
Rev-tubulin interactions
Rev has the propensity to form long filaments in vitro that despite
retaining the ability to bind RNA, have the tendency to aggregate (Heaphy et al.,
1991; Wingfield et al., 1991). These filaments can be depolymerized by polyanions
such as poly-G, poly-dG and poly-glutamate suggesting that Rev may be solubilized
in an negatively charged environment. In an attempt to find the solution conditions
that allow determination of Rev’s structure, Watts et al. (2000) reasoned tubulin an
ideal candidate for structural studies. Tubulin is acidic 50 kDa protein with a Cterminal poly-glutamate tail (also known as E-hooks) exposed on the surface. To
determine the solution conditions needed to study Rev structure, they found that Rev
depolymerized MTs into bilayered ring like structures called Rev-tubulin toroids
(RTTs). The RTTs are also formed with colchicine treated tubulin heterodimers.
RTTs are 3-4 MDa in molecular weight and have a mean outer diameter of 47 nm.
STEM analyses suggested that tubulin lines the outside of RTT with Rev lining the
inside. The apparent stoichiometry of Rev and tubulin is 1:1.
The interaction between Rev and tubulin is specific as RTTs form when Rev
is mixed with rat or bovine tubulin. RTTs do not form when tubulin is incubated with
other basic proteins like histones, lysozyme and poly-lysine. RTTs are stable and
unaffected by changes in pH (6-8) and temperature (4 °C and 25 °C). RTT formation
is unaffected at salt concentration as high as 200 mM. The formation of RTTs
requires Mg++ ions. In the presence of chelating agents, Rev still depolymerizes MTs
but RTTs do not form. Instead, a soluble ≈110 kDa complex corresponding to one
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Rev monomer and one tubulin heterodimer forms. RTTs also form with tubulin
treated with subtilisin, protease that cleaves the C-terminal polyglutamate tail of
tubulin, showing that Rev-MT interactions are not limited to simple electrostatic
interactions. RTT formation occurred with both taxol stabilized MTs and colchicine
treated heterodimers suggesting Rev’s ability to recognize specific surface exposed
residues of tubulin. It also suggests that the binding site for Rev is different from taxol
and colchicine binding sites. RTT formation is however blocked when tubulin dimers
are preincubated with the antimitotic drug maytansine. Since maytansine is known to
bind β-tubulin at or near the vinca site (Sackett, 1995), it is likely that Rev is
interacting with β-tubulin near the GTP binding pocket. The ability to depolymerize
MTs resides in the N-terminal half of Rev as RTTs still form when the first 59 amino
acids are mixed MTs polymerized with GTP. The ring formation by first 59 amino
acids of Rev is inhibited with taxol stabilized MTs. Only short polymeric tubulin arcs
form suggesting that the C-terminus is also important for RTT stabilization (Watts et
al., 2000).
A mechanism that explains Rev-tubulin interactions is suggested by the
presence of a limited sequence similarity between the ARM of Rev and the catalytic
motor domain of MCAK, a potent MT depolymerase and a member of Kinesin-13
group of proteins (Watts et al., 2000; Figure 2). Rev residues Thr34, Arg39, and
Arg42 are shared with MCAK residues Thr506, Arg511, and Arg514 and are thought
to be surface exposed in both proteins. In Rev, they are important for RRE binding
(Battiste et al., 1996). The MCAK residues are vital for MT binding (Ogawa et al.,
2004). Hydrophobic residues Ile52, 55, and 59 that are important for interaction
between helix-1 and 2 in Rev (Thomas et al., 1997) are similar to corresponding
residues in MCAK (Figure 2B) which reside in a helical structure (α4 helix) and are
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important for binding and depolymerization (Neiderstrasser et al., 2001; Shipley et
al., 2004; Ogawa et al., 2004). The α4 helix is thought to bind the intradimer interface
of the MT (Ogawa et al., 2004).
Using the program HEX to model the interactions between tubulin
heterodimers and the ARM peptide (PDB# 1ETF), the ARM is also proposed to bind
tubulin heterodimers at the α and β-tubulin interface (Deacon Sweeney, pers. comm.).
This prediction is consistent with the hypothesis that Rev binds the vinca
(Maytansine) site of tubulin. This region of similarity also includes a part of helix-2 of
the helix-loop-helix model proposed for the N- terminus for Rev.
Rev’s ARM may mimic MCAK in several additional ways because MCAK
has two positively charged regions in addition to the Rev-share sequences
(Neiderstrasser et al., 2002; Ogawa et al., 2004). One of these regions is called the
neck that lies adjacent to the motor domain. In motile kinesins, the neck confers
motor processivity and directionality. In Kinesin-13s, the neck is rich in positively
charged amino acids and is proposed to disrupt lateral interactions between adjacent
protofilaments in a MT during depolymerization (Ogawa et al., 2004). The second
basic region is loop L8 that is important for MT binding (Niederstrasser et al., 2002).
MCAK and MT depolymerization
MCAK is the best characterized member of Kinesin-13 family and plays an
essential role in spindle formation and chromosomal movement during mitosis
(Maney et al., 1998, Ovechina et al., 2002, Kline-Smith et al., 2004). It consists of
three separate domains: an N-terminal domain that targets kinetochores (Maney et al.,
1998, Wordeman et al., 1999), a middle catalytic core preceded by the neck that is
essential for MT depolymerization (Maney et al., 2001, Ogawa et al., 2004), and a Cterminal tail that regulates dimerization and ATPase activity (Maney et al., 2001).
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Maney et al. (2001) and Hertzer et al. (2006) have proposed that the MCAK
monomer forms the minimal active unit but the dimer depolymerizes MTs three-fold
more efficiently. Neiderstrasser et al. (2002) showed that MCAK acts on a single
protofilament because it is able to depolymerize zinc polymerized tubulin, tubulin
sheets made of anti-parallel protofilaments.
The positively charged neck of MCAK is proposed to act as electrostatic
tether by interacting with negatively C-terminus of tubulin making MT
depolymerization efficient (Maney et al., 2001; Ovechina et al., 2002). C-terminal Ehooks of MTs are also required although they are dispensable for binding MCAK
(Neiderstrasser et al., 2002). Limited digestion by protease subtilisin that cleaves Ehooks of tubulin shows that the C-terminal domain of β-tubulin is essential for
microtubule depolymerization (Moores et al., 2002; Neiderstrasser et al., 2002).
Moores et al. (2002) further proposed a model of depolymerization of microtubules
wherein the motor core of pKinI (MCAK homolog in Plasmodium falciparum) binds
to the ends of the microtubules with the subsequent release of ADP. The release if
ADP leads to the binding of ATP that causes a bend in the tubulin dimer. This
conformation change causes release of the dimer from the protofilament, followed by
the dissociation of the motor core and tubulin with the subsequent hydrolysis of ATP
(Moores et al., 2002, Niederstrasser et al., 2002).
A comparison of the molecular structure of ADP bound form of Kif2C
(murine ortholog of MCAK) and Kif1A (a motile kinesin) shows several differences
in the following seven regions that are well conserved in Kinesin-13 group (Ogawa et
al., 2004). Six of these regions (L2, α2-L5, L8-α3-L9, L10, L11-α4-L12, α6) form a
part of the characteristic, conserved motor domain of Kinesin-13 group of proteins,
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the seventh being the neck region. Two of these regions, loop L8 and α4 helix, are
shared with Rev (Ogawa et al., 2004).
The Loop L2 in Kif2C has a characteristic ‘KVD’ motif (Lys293, Val294,
Asp295) that forms a long, rigid finger like projection. This motif is appreciably
smaller in Kif1A and mutation in this region reduces MT depolymerization
significantly in Kif2C. The L5 loop is larger in Kif2C than Kif1A and is conserved in
various members of Kinesin-13 family. The C-terminus of α2 helix is kinked at
Pro384 in Kif2C. The longer L5 and kinked α2b displace the main α2 helix by 10° in
clockwise direction. This results in likewise rotation in following α3 helix that further
results in change in positions of Loop L8 (lysine-arginine loop), which is proposed to
serve as a sensor for regulation of ATP hydrolysis, and L9. Residues Asp502-Arg 506
at the end of L11 are wound up in α4 helix (the main MT binding region, Rev
homology region), which make α4 helix longer in Kif2C and tilts it 5° compared to
Kif1A.
X-ray chrystallographic studies and in silico modeling suggests that the class
specific residues at the end of α4 helix of the motor domain of Kif-2C binds the
curved MT end and link the poly-glutamate tail of β-tubulin with α-tubulin (Ogawa et
al., 2004). The crosslinking of the poly-glutamate tails of the α- and β-tubulin
stabilizes the curved structure of the intradimer interface and causes the initiation of
ATP hydrolysis in Kif2C. Crosslinking also facilitates the insertion of KVD finger
(absent in motile kinesins) in the interdimer interface and stabilizes the curved
conformation of the protofilament. Mutating KVD impairs MCAK’s ability to
depolymerize MTs (Shipley et al., 2004). The N-terminal region buries between
protofilaments thus destabilizing the lateral interaction between of the protofilaments
(Ogawa et al. (2004). Shipley et al. (2004) have also suggested that loop L11 and L2,
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on the either side of motor core of pKinI form the anchor points on MTs. They have
further suggested that mutating the KEC residues of the α4 helix inhibits MCAK’s
ability to depolymerize MTs (Shipley et al., 2004). Mutating the ‘E’ residue of KEC
in the α4 helix inhibited MCAK-MT binding (Ems-McClung et al., 2007). Rev also
has a conserved ‘E’ at position 57 similar to the ‘E’ residue of KEC, and this E57 in
Rev also forms a part of helix-2 in Rev, suggesting that E57 might be playing an
important role in MT interaction.

20

MODEL AND SPECIFIC AIMS
Any model that explains Rev-tubulin interactions must provide a mechanism
that explains how Rev binds the MTs, how MT ends are peeled from the MT polymer,
and ultimately how RTTs form.
Binding: There are several possible explanations explaining how Rev is able to bind
MTs. The simplest explanation of electrostatic interactions between the ARM and Ehooks seems unlikely given the observation that RTT formation occurs even when the
E-hooks are removed by subtilisin treatment (Watts et al., 2000). The primary binding
determinants must reside with the N-terminal 59 residues of Rev that can still form
RTTs. These 59 residues includes the helix-loop-helix motif, the ARM and both
multimerization domains as well as sequences shared with Kinesin-13 depolymerases
(Watts et al., 2000; Neiderstrasser et al., 2002). Both the motor domain of Kinesin-13
proteins and ARM of Rev have been proposed to bind at the intradimer interface of
MTs further supporting similar binding mechanism (Deacon Sweeney, per.comm.;
Ogawa et al., 2004). The shared sequences and secondary structures of Rev and motor
domain of Kinesin-13 protein raise the possibility of ARM of Rev involved in MT
binding.
Considering the similarities between Rev’s ARM and Kinesin-13 proteins,
Rev may be interacting with MTs in a manner similar to Kinesin-13-MT interaction.
Rev’s ARM may mimic the neck of Kinesin-13 proteins that is also rich in positively
charged residues, regulates MT binding and is essential for MT depolymerization by
disrupting of lateral interactions between protofilaments. It is also a possibility that
Rev’s ARM may be acting like MT binding Loop-8 of MCAK thus aiding in
establishment of mutiple contacts on MTs.
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Depolymerization: MCAK has three distinct positively charged regions that help in
MT depolymerization. The positively charged neck region helps in disrupting the
lateral interactions between the MT protofilaments at MT ends (Ogawa et al., 2004).
Rev’s ARM may behave similarly. The ARM may also act like the α4 helix of the
catalytic domain of MCAK. The α4 helix is suggested to stabilize the curved
conformation of MT ends (residues 268-270, 272). Since Rev shares the sequence
similarity with this region of MCAK, there is a possibility that Rev’s ARM may be
acting in a similar manner. The similarities include but are not limited to Arg514 of
MCAK, which is similar to Arg42 of ARM of Rev, which is mutated in M6. Another
residue, Glu530, which when mutated in MCAK, inhibits its ability to depolymerize
MT. Rev has a similar residue at position 57, suggesting that this amino acid may be
participating in Rev’s interaction with MTs. Similar possibilities exist for other shared
residues mentioned in Figure 2B, supporting the possibility of similarity in
mechanism for Rev-MT interactions. The third possibility is that Rev’s ARM may be
acting like the Lys-Arg loop of MCAK, involved in binding MTs (Ogawa et al.,
2004). During MT depolymerization when MCAK binds the MT ends, the neck
region causes the disruption of lateral interaction between the protofilaments, loop L8
in the Lys-Arg loop region causes the hydrolysis of ATP while the α4 helix causes the
stabilization of the curved conformation of MT ends. Rev might be acting in a similar
way wherein the multimerizing Rev induces the curved conformation of MT ends and
the ARM may act like neck or the α4 helix (the two positively charged regions of
MCAK) to cause MT depolymerization.
RTT Formation: Watts et al. (2000) suggest that Rev causes MTs to peel outward
forming RTTs. The formation of RTTs by outward peeling of MTs is consistent with
tubulin lining the outside and Rev lining the inside of RTTs. During the formation the
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RTT, it is possible that Rev binds the lattice, multimerizes on it and as it reaches the
ends, it exerts an outward bending force needed to peels the protofilament from the
MTs, like peeling a banana. Alternatively, it is possible that multiple Rev monomers
bind the lattice first, multimerize until the MT end is reached, and MTs peel into
rings. In either case, Rev multimerization provides multiple contacts on the surface of
the MT and has the potential to generate a ripping/bending force required to make an
RTT.
The formation of bilayered rings suggests that Rev may act upon two MT
protofilaments at a time although it is formally possible that single layered rings form
first that subsequently join. The second of the above two possibilities is supported by
the fact that RTTs also form with tubulin heterodimers. The possibilities mentioned
above support the idea that there might be a lateral interaction (dimerization) between
Rev molecules in adjacent layers in a bilayered RTT.
Dimensional Considerations in an RTT: Watts et al. (2000) proposed a model of
RTT in which 15 tubulin heterodimers lining the outside of the ring and 30 Rev
monomers line the inside. The width of a tubulin monomer (4.3 nm) agrees well with
the spacing of tubulin seen in the outer rim of RTT (Watts et al., 2000). The inner rim
of the ring had a spacing of 3.3 nm, consistent with the size of Rev dimers present in
the Rev filaments (Watts et al. (1998). The above findings that the inner rim in an
RTT has a spacing of 3.3 nm and that the width of a Rev dimer is 3.2 nm suggests that
Rev may be binding tubulin heterodimers as a dimer (Figure 3). Since the diameter of
the base of the ‘Top Hat’ is not sufficient (3.2 nm of Rev dimer as compared to 8 nm
of a tubulin heterodimer) to interact with the adjacent Rev dimer (multimerization),
the bound Rev dimer might introduce additional bends in the conformation of the
heterodimer. There is also a possibility that the adjacent Rev dimer do not interact
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with each other in the same layer (this could be due to limited ability of heterodimer
to curve) but interact with the Rev dimer of the neighboring layer thus further aiding
in formation of a bilayer (Figure 3).
Specific Aims
Rev and Kinesin-13 proteins share more than a sequence similarity. Both
depolymerize MTs (Watts et al., 2000; Desai et al., 1999). Both form rings when
mixed with MTs (Watts et al., 2000; Desai et al., 1999; Moores et al., 2002).
Moreover, like Rev, MCAK homo-oligomerizes albeit it is only a dimer. Dimeric
MCAK is a more potent depolymerase than the monomer by a factor of three (Hertzer
et al., 2006). Since Rev is also capable of multimerizing, I tested the hypothesis that
Rev multimerization is important for MT depolymerization. To test this
hypothesis, I compared and contrasted the ability of the multimerization defective
mutant M4 form RTTs and depolymerize MTs to the wild-type protein using assays
commonly used to monitor Kinesin-13 activity.
I have also tested the hypothesis that residues 41-44 in the ARM are
important for Rev- MT interactions. Residues 41-44 are critical for RRE binding
and comprise a part of Rev-Kinesin-13 shared region. For these experiments, I will
compare the M6 mutant with wild-type Rev for its ability to depolymerize MTs and
form RTTs. Mutation in M6 includes Arg42 that is similar to critical residue Arg514
that lies in MT binding region of MCAK. Inability of M6 to interact with tubulin will
show that residues 41-44 form a minimum region in Rev responsible for binding and
depolymerization. Conversely, formation of any kind of complex, determined by
combination of sedimenation assays, gel filtration assays and electron microscopy,
will suggest the role of other shared residues in ARM. Taken together, I
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Figure 3: Proposed spatial arrangement of Rev and tubulin in RTT. A) Rev binds
the intradimer interface of tubulin as a dimer. The interaction between adjacent Rev
dimer (top hat) on the tubulin intradimer interface creates a force required for
introducing the curved conformation in the terminal heterodimer in a MT and cause
depolymerization. B) Alternatively, Rev bound to one tubulin heterodimer may
multimerize with a Rev dimer bound to diagonally opposite heterodimer on the
neighboring protofilament, together generating the force required for MT peeling and
RTT formation.
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have tested the above hypothesis by performing experiments that test whether
residues 23, 25 and 26 are required for binding tubulin heterodimers and forming
RTTs. I have also performed experiments that test the importance of these residues in
MT depolymerization.
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MATERIALS AND METHODS
Rev purification
Rev and mutants: The plasmid pET11D-Rev encoding wild-type Rev was kindly
provided by Dr. Blanco (Blanco et al., 2001). Point mutations were introduced in the
wild-type gene using the Quikchange Site Directed Mutagenesis Kit (Stratagene Inc.,
CA), using primers listed in Appendix A and confirmed by double stranded
sequencing (Davis Sequencing, Davis CA). The wild-type and mutant plasmids were
perpetuated in E.coli DH5α cells and stored in 15% glycerol stocks at -80°C.
To express Rev, BL21(DE3) cells were transformed with Rev expression
plasmids that were grown and selected on Luria-Bertini (LB) agar plates
supplemented with 50 µg/ml ampicillin. Large scale 1 L LB/amp cultures were
inoculated with 50 ml overnight cultures initiated from a single colony from a plate
stock. All cultures were grown at 37°C with 250 rpm shaking. Expression of Rev was
induced with the addition of 1 mM IPTG when cultures exhibited exponential growth
(OD600≈0.6). Two hours later, cells were harvested by centrifugation at 5,000 x g for
10 min. Cell pellets were frozen at -80ºC until Rev was purified.
Purification: Cell pellets were resuspended in a buffer A (50mM Tris-HCl pH 8.0, 1
mM DTT, 1 mM EDTA, and 5 mM PMSF) supplemented with 400 mM NaCl and
lysed by sonication, three 30 s pulses at 10 w. Sonicates were frozen at -80ºC for five
minutes, quickly thawed and sonicated as before. Sonicates were clarified by
centrifugation at 12,000 x g for 10 min in a SS34 rotor (Sorvall, CA) and FPLC
purified using the methods of Karn et al. (1995). Briefly, lysates were fractionated
using a Q-Sepharose column (GE Life Sciences, NJ). The column was washed with
buffer A plus 400 mM NaCl and Rev-RNA complexes were eluted with buffer B
(Buffer A plus 800 mM NaCl). The eluate was collected and fractioned using a
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Heparin-Sepharose column (GE life sciences, NJ). The column was washed with five
column volumes of buffer B followed by five column volumes of buffer C (Buffer A
plus 1 M NaCl). Rev was eluted with buffer D (Buffer A plus 2 M NaCl). The
presence of Rev was confirmed by immunodetection using Rev specific antibodies
and the purity confirmed by SDS-PAGE and coomassie brilliant blue staining. Figure
4 shows representative results of purification.
Rev obtained from heparin-sepharose chromatography was monomeric owing
to the high salt concentration (2 M) that must be diluted before mixed with MTs. MTs
depolymerize in 500 mM salt (Mendez, 1998). However, because Rev aggregates
under low salt conditions (Wingfield et al., 1991, Watts et al., 2000), purified Rev
was denatured and refolded into filaments using the methods of Watts et al. (1998)
and concentrated by ultrafiltration (Centricon-30) or ultracentrifugaton (320,000 x g,
4

hours,

in

a

TLA100

rotor).

Protein

concentrations

were

determined

spectrophotometrically (ε=8.31 mM-1cm-1) and by densitometric scanning of
coomassie stained proteins relative to BSA standards resolved by SDS-PAGE using
ImageJ (Rasband, 1997-2007).
Alternatively, wild-type and M4 were also purified with an alternative
modified protocol derived from Wingfield et al. (1991). In the modified protocol the
DEAE-sepharose and Fast S columns are substituted with Q-sepharose and heparinsepharose columns, respectively. Rev-expressing cell pellets from 1 L cultures of E.
coli were sonicated as above in lysis buffer (0.1 M Tris-HCl, pH 8.0, 5 mM DTT,
5mM PMSF, 5mM benzamidine and 5 mM EDTA). Sonicates were subjected to
10,000 x g centrifugation for 10 min. The supernatant was collected and further
subjected to a spin at 60,000 x g for one hour. The supernatant was collected and
diluted 3 fold in buffer containing 50 mM Tris-HCl, pH 8.0, 1 mM sodium azide and
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applied over Q-sepharose column. Rev eluted in the flow-through fractions, which
were collected and supplemented adjusted to 6.5 using phosphoric acid. The Rev
containing solution was then applied over with solid urea to a final concentration of 6
M. The resultant solution was diluted in buffer E (0.02 M sodium phosphate, pH 6.5,
1 mM EDTA, 1mM DTT and 2 M urea) and pH heparin-sepharose column. The
column was then washed with buffer E which was followed by application of a five
column volume gradient of NaCl (0-1 M) in buffer E. Rev elutes off at 0.5 M NaCl
which was than subjected to refolding and concentration determination as described
above.
M6 purification: Rev purified using the above methods relies on the ability of Rev to
bind cellular RNA which then binds the Q-sepharose column. This complex is then
dissociated by high salt and Rev is purified exploiting its affinity for heparin.
However, this procedure does not work well for M6 that has reduced affinities for
RNA and heparin. To purify M6, I used a modified protocol derived from Wingfield
et al. (1991). Bacterial cell lysates clarified by 60,000 x g centrifugation were
introduced over Q-Sepharose column under no salt conditions (0.1 M Tris-HCl, pH
8.0, 5 mM DTT, 5mM PMSF, 5mM benzamidine and 5 mM EDTA). The absence of
salt allows for limited Rev aggregation, which elutes off separating it from nucleic
acids (bound to the column). Rev, present in the flow-through, is denatured in 6 M
urea, and subjected to refolding as described above in the Rev purification section.
Since M6cannot be completely purified, BL21(DE3) E.coli whole cell extracts were
used as a control.
Tubulin Purification
Tubulin was purified from freshly procured bovine brains according to the
methods of Walczak and Desai, 2001. Briefly the meninges are stripped and brains
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were homogenized in Pipes buffer (PB) (0.1 M K-Pipes pH 6.8, 0.5 mM MgCl2, 2
mM EGTA, 0.1 mM EDTA, 0.1 % β-mercaptoethanol, 1 mM ATP). The lysate was
centrifuged at 33,000 x g for 2 hr at 4°C using a GS3 rotor (Sorvall). The supernatant
was collected and supplemented with 1.5mM ATP, 0.1 mM GTP, 3.5 mM MgCl2 and
50% glycerol (final concentrations) and incubated at 37°C, 1 hr. The extract was
subjected to centrifugation at 33,000 x g, 165 min, 35°C. The pellet was recovered,
resuspended in cold PB, homogenized in presence of additional 1 mM ATP and 0.1%
β-mercaptoethanol, and incubated at 4°C, 40 min. The homogenate was subjected to
centrifugation at 190,000 x g, 30 min, 4°C, in a Beckman type 50.2 Ti rotor and the
supernatant containing tubulin heterodimers was recovered. The supernatant was
supplemented with warm 50% glycerol, 0.5 mM GTP and 4 mM MgCl2, at 37°C for 1
hr. The extract was centrifuged at 240,000 x g 30 min centrifugation at 35°C, in a
Beckman type 50.2 Ti rotor. The pellet was resusupend in column buffer (CB) (50
mM K-Pipes, pH 6.8; 1 mM EGTA; 0.2 mM MgCl2). The pellet was dounce
homogenized and incubated at 4ºC for 40 min to depolymerize MTs. The supernatant
was recovered after centrifugation at 190,000 x g, 30 min, 4°C and applied over a 200
ml phosphocellulose (PC) column equilibrated in CB. Tubulin present in the flowthrough fractions was collected, pooled and flash frozen in 7 ml aliquots in liquid
nitrogen (Figure 5). This tubulin was called PC tubulin. A small fraction was used to
determine the concentration using spectrophotometric (O.D. 280 nm, ε of tubulin
115,000 M-1cm 1) and densitometric methods using ImageJ and bovine gamma
globulin as a standard.
Sedimentation assays
Purified tubulin heterodimers were diluted to 3 µM in MEM (100 mM MES, 1
mM EGTA, 2 mM MgCl2, pH 6.9) on ice for 10 min and clarified by 360,000 x g
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centrifugation using a TLS optima centrifuge. In some experiments, the supernatant
was supplemented with 50 µM colchicine (Sigma, St. Louis, MO) and diluted to the
desired concentration in MEM.

In other experiments, the supernatant was

supplemented with GMPcPP to 1 mM final concentration and incubated at 37˚C for
30 min.

Polymerized microtubules were recovered by 360,000 x g, 5 min

centrifugation at 37˚C and diluted to twice the desired final concentration in MEM.
Rev was diluted in MES (100 mM MES, 2 mM MgCl2, pH 6.9) to twice the desired
final concentration (~10 µM) immediately before use. In most instances, MgCl2 was
added ensuring the final concentration was 1-2 mM above the citrate concentration.
Reactions were initiated by mixing equal volumes of tubulin or microtubules with
Rev for prescribed times at room temperature. Samples were subjected to 5 min,
360,000 x g centrifugation. Pellet and supernatant fractions were recovered and the
proteins present in each were resolved by SDS-PAGE (Desai and Walczak, 2001).
Gels were stained with coomassie brilliant blue and the amount of tubulin present in
each fraction was quantified using ImageJ (Rasband, 1997-2008). In some instances,
proteins were transferred to nitrocellulose membranes at 50 mV for 1.5 hr in transfer
buffer (25 mM Tris, pH 8.3, 192 mM glycine, 20% ethanol). Rev and tubulin were
detected by immunoblotting using protein specific antibodies (sheep anti-Rev, US
Biologicals, Swampscott, MA; DM1a, Sigma, St. Louis, MO).
Transmission electron microscopy (TEM)
Aliquots (5 µl) of mixtures described above were spotted onto a carbon coated
mica grid (Ted Pella, CA). After 1 min, excess sample was wicked away and the
sample was fixed with 1% uranyl acetate for 20 s. The sample was stained with 1%
uranyl acetate for 1 min, air dried and visualized with a Philips EM 208S electron
microscope at 56000x magnification.
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Gel filtration chromatography (superdex-200)
Mixtures of Rev and colchicine-treated tubulin were resolved on a Superdex200 gel filtration column equilibrated with 150 mM sodium phosphate (pH 7.2) and
50 mM sodium chloride. Aliquots of collected fractions were resolved by SDSPAGE, and transferred onto nitrocellulose membranes.

Rev and tubulin were

detected using protein specific antibodies.
Statistical Analysis
Statistical analysis for data obtained from sedimentation assays involving
tubulin heterodimers and Rev (in presence and absence of Mg++) was performed using
one-way ANOVA. When required, Tukey’s HSD posthoc testing was used.
Regression model, Bonferroni corrections and students T-test analyzed data
obtained from sedimentation assays.
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RESULTS
Purification of tubulin, wild-type Rev, M4 and M6
Wild-type Rev, M4 and M6 were over-expressed in BL21(DE3) cells and
purified using FPLC, as described in “Materials and Methods”. Presence of Rev was
confirmed using Rev specific antibodies. Whereas purified wild-type Rev and M4
were largely devoid of impurities, M6 was not comparably purified because it did not
bind the heparin column (Figure 4). Despite the impurities, TEM analysis
demonstrates that wild-type Rev and M6 form similar ≈13 nm filaments, consistent
with the published work (Figure 5) (Watts et al., 1998). There were no signs of
filament bundling or aggregation. On the contrary, M4 did not form filaments. Large,
irregular shaped, high molecular weight complexes were present, consistent with the
idea that the M4 mutation inhibits Rev-Rev interactions (Figure 5). Tubulin was
purified from bovine brains, as described in “Materials and Methods” (Figure 6).
Measuring interactions between wild-type Rev and tubulin heterodimers
Sedimentation assays were performed to determine whether Rev binds tubulin
and forms high molecular weight complexes. These assays are routinely used to
characterize MCAK-MT interactions (Desai and Walczak, 2001). To compare the
ability of Rev to interact with tubulin and form high molecular weight complexes,
different concentrations of Rev were incubated with tubulin for 10 minutes and
centrifuged at 360,000 x g. In the absence of Rev, tubulin heterodimers fractionate
into the supernatant following centrifugation. However, with the addition of different
concentrations of wild-type Rev in the presence of Mg++, significant amounts of
tubulin fractionates into the pellet (one-way ANOVA; p=0.013). Posthoc test using
Tukey’s HSD demonstrates that significant amount of tubulin fractionates in the pellet
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Figure 4: Rev Purification. Representative results of proteins resolved by SDSPAGE. Rev expressed in BL21(DE3) cells were lysed, fractionated (bound and
eluted) using Q-Sepharose (A) and heparin-sepharose (B). Purified wild-type Rev,
M4 and M6 used in the experiments are shown in C, D and E respectively. Gels are
stained with coomassie brilliant blue. The markers in A and B correpond to 180 (top),
115, 82, 64, 49, 37, 26, 19, 15 and 6 kDa (bottom). The markers in C, D and E
correpond to 170 (top), 135, 100, 72, 55, 42, 33, 24, 17 and 11 kDa (bottom).
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Figure 5: Electron micrographs of purified Rev and mutants: A. purified and
refolded wild-type Rev, B. M4, and C. M6. Magnification bar correspond to 200nm.
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Figure 6: Tubulin Purification. Tubulin was purified as described in materials and
methods. A representative coomassie stained gel, depicting tubulin (A) separated
from MAPS (B) after phosphocellulose chromatography.
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at 1:1 Rev-tubulin heterodimer ratios ( p<0.05). The formation of high-molecular
weight complexes is consistent with the formation of RTTs (Figure 7). Although not
statistically significant, more tubulin is detected in the pellet fractions at lower
concentrations than is seen with the wild-type protein (Figure 7). Sedimentation
assays further show that compared to no Rev control, product formation takes place at
1:1 wild-type Rev monomer/tubulin heterodimer molar ratio in the absence of Mg++
(one-way ANOVA, p<0.0001) (Figure 7). However, high molecular weight
complexes were absent below Rev monomer-tubulin ratio of 1:1 (Figure 7).
The formation of pelletable complex in the absence of Mg++ is contradicts the
results obtained by Watts et al. (2000). To investigate the formation of pelletable
products in the absence of Mg++ and to determine the sizes of products formed in the
absence and presence of Mg++, S200 size exclusion chromatography was performed.
Size exclusion chromatography provides the advantage of separating high molecular
weight complexes based on size, with larger complexes eluting out faster whereas the
smaller ones have to pass through the pores of the chromatography beads. In the
absence of Rev, colchicine-treated tubulin elutes in fractions 15 corresponding to the
size of 142 kDa (Figure 8). 500 µl fractions were collected during gel filtration
chromatography which may explain the calculated size of tubulin heterodimer to be
142 kDa and not 110 kDa. It is a possibility that collection of smaller fractions may
provide a better approximation of the size of the tubulin heterodimer.
The peak in the chromatogram is broad suggesting the presence of oligomers
of tubulin in addition to heterodimers. When Rev-tubulin heterodimer mixtures in 1:1
molar ratio were resolved in the absence of Mg++, Rev and tubulin eluted in fractions
corresponding to ≈142 kDa (Figure 9). The formation of similar-sized complexes in
the presence and absence of Rev suggest that the experiments in the absence of Mg++
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Figure 7: Wild-type Rev forms high molecular weight complexes when mixed
with tubulin heterodimers. A. Coomassie stained gel showing tubulin present in the
supernatant (S) and pellet fractions (P) after tubulin heterodimers are mixed with
different concentrations of wild-type Rev in the presence of Mg++. B. Graphical
representation of the quantification of tubulin heterodimers in the (S) fraction after
incubation with wild-type Rev, in the presence of Mg++. C. Coomassie stained gel
showing tubulin present in the (S) and (P) fractions after tubulin heterodimers are
mixed with different concentrations of wild-type Rev, in the absence of Mg++. D.
Graphical representation of the quantification of tubulin heterodimers present in the
(S) fraction after incubation with wild-type Rev, in the absence of Mg++. Black star
corresponds to p<0.05 (one-way ANOVA, n=15; PostHoc test using Tukey’s HSD);
Red stars corresponds to p<0.0001 (one-way ANOVA, n=12; PostHoc test using
Tukey’s

HSD).
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Figure 8: Gel filtration of reactions involving Rev and its mutants with tubulin
in the presence of Mg++. Representative chromatograms from S200 gel filtration
chromatography (presence of Mg++) and immunoblots detecting tubulin (black arrow)
and Rev (red arrow) present in the designated fractions for A. Colchicine treated
tubulin alone, B. Wild-type Rev and colchicine treated tubulin, C. M4 and colchicine
treated tubulin, and D. M6 and colchicine treated tubulin. Representative
chromatograms from S200 gel filtration chromatography of gel filtration standards:
E) Dextran Blue (black arrow, 2 MDa), F) Molecular weight standard proteins
showing elution peaks for Ferritin (F, 440 kDa), Aldolase (A, 158 kDa), Conalbumin
(C, 75 kDa) and Ribonuclease A (R, 13.7 kDa).
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Figure 9: Gel filtration of reactions involving Rev and its mutants with tubulin in
the absence of MgCl2. Representative chromatograms from S200 gel filtration
chromatography (absence of Mg++) and immunoblot for Tubulin (black arrow) and
Rev (red arrow) in corresponding fractions for A. Wild-type Rev and colchicine
treated tubulin, and B. M4 and colchicine treated tubulin, C. M6 and colchicine
treated tubulin.
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need to be performed using gel-filtration column that will facilitate better resolution
of complexes. The absence of Rev-tubulin complex in the void volume however
suggests that the pelletable complex detected in the sedimentation assays in the
absence of Mg++ may be the rings that are unstable and hence not detected during the
S200 chromatography.
Chromatography of Rev:tubulin (1:1 molar ratio) mixtures supplemented with
Mg++ show a significant amount of Rev and tubulin elute in the void volume
(fractions 9 and 10), corresponding to complexes with sizes greater than Mr≈ 500 kDa
(Figure 8). The presence of tubulin and Rev in the void volume suggests the
formation of high molecular weight complex that is consistent with presence of RTT.
To determine whether the materials in the pellets are RTTs, aliquots of Revtubulin mixtures were spotted on a carbon coated mica grid, stained with 1% uranyl
acetate, dried and visualized using TEM. RTTs formed at 1:1 molar ratio of Rev
monomer and tubulin heterodimer (Figure 10). Consistent with the diameter of RTTs
observed by Watts et al. (2000), the majority of RTTs observed during this study
were ≈ 40 nm in diameter.
Taken together these data confirm the results of Watts et al. (2000), validate
the sedimentation assays and show that Rev used in the study is functional.
Measuring interactions between M4 and tubulin heterodimers
Sedimentation assays show that M4 bound tubulin heterodimers significantly
in the presence of Mg++ in a concentration dependent manner (one-way ANOVA p<
0.0078) (Figure 11). Post hoc tests performed using Tukey’s HSD demonstrated that
complex formation was significant at concentrations ≥ 1.5 µM (p<0.05). Although
M4 appears to sediment more tubulin than the wild-type protein, these differences are
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Figure 10: Electron micrographs of mixtures of tubulin heterodimers in Rev
buffer (A), with wild-type Rev (B), M4 (C) and M6 (D): Black, yellow and red
arrows point to complexes formed with wild-type Rev, M4, and M6, respectively.
Magnification bar correspond to 200 nm.
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Figure 11: Sedimentation assays with M4 and tubulin. A. Coomassie stained gel
showing tubulin concentration in the supernatant (S) and pellet fraction (P) when
tubulin heterodimers are incubated with varying concentration of M4, in the presence
of Mg++. B. Graphical representation of the quantification of tubulin heterodimers in
the (S) fraction after incubation with M4 in the presence of Mg++. C. Coomassie
stained gel showing tubulin concentration in the (S) and (P) fraction when tubulin
heterodimers are incubated with varying concentration of M4, in the absence of Mg++.
D. Graphical representation of the quantification of tubulin heterodimers present in
the (S) fraction after incubation with M4 in the absence of Mg++. Black stars
correspond to p=0.05 (one-way anova, n=15; Posthoc test using Tukey’s HSD). Error
bars correspond to standard deviations.
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not statistically significant (one-way ANOVA; p=0.8). M4 did not form high
molecular weight complexes in the absence of Mg++ (one-way ANOVA; p=0.5)
(Figure 11).
S200 gel filtration chromatography was performed to investigate the sizes of
the complex formed by M4. The results in the presence of Mg++ show that similar to
wild-type Rev, RevM4 formed high molecular weight complexes that elute out in the
void volume and contain both Rev and tubulin (Figure 8). Elution of tubulin and Rev
together in fractions 15 and 16 suggests that only low molecular weight complexes
(consisting of both Rev and tubulin) are observed in the absence of Mg++ (Figure 9).
TEM analysis in the presence of Mg++ shows that M4 does not form RTTs.
Instead heterogeneous clusters are seen (Figure 10). Sedimentation assays conducted
in parallel with TEM show that almost 94% of tubulin shift from the supernatant to
pellet fraction after incubation with M4 (Figure 12).
These data collectively argue that the M4 mutation does not block tubulin binding or
the formation of high molecular weight complex formation. However, it does block
RTT formation.
Measuring interactions between wild-type Rev and MTs
Previous studies suggest that wild-type Rev depolymerizes GMPCPP
polymerized MTs into spirals (Watts et al., 2000). GMPCPP is a slowly hydrolysable
analog of GTP and prevents MT from spontaneously depolymerizing during the
course of experiments. To compare the abilities of wild-type Rev and M4 to
depolymerize stabilized MTs, sedimentation assays were conducted. In the absence of
Rev, stabilized MTs sediment in the pellet fraction after high-speed centrifugation.
Rev’s effect on MTs can be determined by observing release of tubulin heterodimers
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Figure 12: Sedimentation assays corresponding TEM of wild-type Rev, M4 with
tubulin A. Coomassie stained gel showing tubulin present in supernatant (S) and
pellet (P) fractions in absence of Rev and when tubulin is incubated with wild-type
Rev and M4, in the presence of Mg++. B. Graphical representation of tubulin in
supernatant fraction after it is treated with wild-type Rev and M4. C, D, and E.
Representative electron micrographs of tubulin alone (C), RTT formed in presence of
wild-type Rev (D) and high molecular weight complex in presence of M4 (E).
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in the supernatant fraction. However, measuring depolymerization is complicated by
the fact that any tubulin released from MTs may bind Rev and form RTTs (Figure
10). Since RTTs also fractionate into the pellet, the true amount of tubulin present in
the supernatant will be underestimated. However, sedimentation assays can be used to
qualitatively demonstrate MT depolymerization stimulated by Rev addition.
Sedimentation assays reveal that wild-type Rev releases significant amounts of
tubulin heterodimers from MTs both in the presence and absence of Mg++ (linear
regression and Bonferroni correction; p<0.04 and p<0.0001, respectively) (Figure 13).
Statistical analysis also shows that depolymerization is more significant in the
absence of Mg++ than in the presence of Mg++ (linear regression and Bonferroni
correction; p<0.01). More depolymerization in the absence of Mg++ is consistent with
the finding that the presence of Mg++ promotes high molecular weight complex
formation that may prevent detection of released tubulin during sedimentation assays
with Rev and MTs. Even at Rev:tubulin heterodimer stoichiometries of >1:1, roughly
50% of the tubulin remained in the pellet suggesting either that Rev is unable to
depolymerize all the MTs in the sample or that some of the depolymerization products
are formings RTTs or other high molecular weight complexes.
TEM of Rev-MT mixtures show that MT and RTTs are both present in these
samples (Figure 14). MTs are shorter (≈16.4 µm compared to control MTs that were
≈33 µm) (one-way ANOVA; p<0.0001) and their ends appeared disorganized,
consistent with microtubule depolymerization. Their edges appear darkly stained and
fuzzy suggesting that Rev is coating the lattice. Measurement of fluorescently labeled
microtubules confirms there are two-fold fewer and ≈50% shorter microtubules -
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Figure 13: Sedimentation Assay of wild-type Rev and MTs A. Coomassie stained
gel showing tubulin mass in the supernatant (S) and pellet (P) fraction when
GMPCPP polymerized MT are incubated with varying concentration of wild-type
Rev, in the presence of Mg++. B. Graphical representation of the quantification of
tubulin heterodimers released in the (S) fraction after incubation with varying
concentration of wild-type Rev in the presence of Mg++. C. Coomassie stained gel
showing tubulin concentration in the (S) and (P) fraction when GMPCPP polymerized
MT are incubated with varying concentration of wild-type Rev, in the absence of
Mg++. D. Graphical representation of the quantification of tubulin heterodimers
released in the (S) fraction after incubation with varying concentration of wild-type
Rev in the absence of Mg++. Depolymerization is more efficient in the absence of
Mg++ with p=0.01 (linear regression and Bonferroni corrections; n=49). Black stars
represents p=0.04 (linear regression and Bonferroni corrections; n=15). Error bars
correspond to standard deviations.
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Figure 14: TEM analysis of Rev and its mutants with MTs. Electron micrographs
of GMPCPP stabilized MTs treated with: A. Control buffer, B. Wild-type Rev, C.
M4, D. M6. Black arrow in panel D points to the presence of M6 filament in the
presence of MTs and are absent in case of wild-type Rev and M4. Magnification bar
correspond to 200 nm.

61

A.

B

C

D

62

-present in samples containing Rev compared to control samples (one-way ANOVA;
p<0.001) (Figure 15).
Measuring interactions between M4 and MTs
Sedimentation assays demonstrate that M4 is unable to depolymerize MTs
both in the presence and absence of Mg++ (linear regression and Bonferroni
correction; p=0.7 and p=0.18 respectively, Figure 16). Wild-type Rev depolymerized
microtubules better than M4 (regression and Bonferroni correction; p<0.05) (Figure
13) and fluorescence micrographs (Figure 15) show M4 causes MTs to bundle in
contrast to wild-type Rev that depolymerizes MTs.
These data show that wild-type Rev and not M4 depolymerizes MTs.
Conversely, M4 appears to stimulate MT bundling. This is consistent with the
hypothesis that M4 mutation does not affect MT binding. Instead, the orientation of
M4 binding is altered in a manner that allows MT cross-linking. These results are
further consistent with the hypothesis that multimerization is important for MT
depolymerization.
Measuring interaction between M6 and Tubulin heterodimers
The ability of M6 to form high molecular weight complexes with tubulin
compared to wild-type Rev was evaluated using sedimentation assays. Because M6
does not purified as extensively as wild-type Rev, I wished to determine the ability of
non-specific proteins present in bacterial cell extracts to interact with tubulin.
Addition of this control extract (total protein quantity 11 ng, corresponding to
equivalent amount of Rev in 3 µM Rev) to tubulin heterodimers had no demonstrable
interactions with tubulin as detected by the sedimentation assays (Figure 17). In the
absence of Rev, tubulin heterodimers fractionate into the supernatant indicating that
tubulin binding proteins are not present in control bacterial extracts. In contrast to
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Figure 15: Immunoflorescense of wild-type Rev and M4 and MTs. A.
Immunoflorescence micrographs showing A. MT of varying size in the absence of
Rev stained with α-tubulin antibodies. B. MT reduced in length due to
depolymerization in the presence of wild-type Rev. C. MT bundles in the presence of
M4.
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Figure 16: Sedimentation Assays of M4 with MTs. A. Coomassie stained gel
showing tubulin concentration in the supernatant (S) and pellet (P) fractions when
GMPCPP polymerized MT are incubated with varying concentrations of M4, in the
presence of Mg++. B. Graphical representation of the quantification of tubulin
heterodimers released in the supernatant (S) fractions after incubation with varying
concentrations of M4 in the presence of Mg++. C. Coomassie stained gel showing
tubulin concentration in the supernatant (S) and pellet (P) fraction when GMPCPP
polymerized MT are incubated with varying concentration of M4, in the absence of
Mg++. D. Graphical representation of the quantification of tubulin heterodimers
released in the supernatant (S) fractions after incubation with varying concentrations
of M4 in the absence of Mg++. Error bars correspond to standard deviations.
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Figure 17: Effect of WCE on tubulin and MTs. A. Coomassie stained gel showing
tubulin in supernatant (S) and pellet (P) fraction after high speed centrifugation
(360,000 x g) of tubulin alone and tubulin treated with 11 ng of whole bacterial cell
extract (WCE). B. Coomassie stained gel showing tubulin in supernatant (S) and
pellet (P) fraction after high speed centrifugation (360,000 x g) of MT alone and MT
treated with BL21(DE3) E.coli (WCE). C. Electron micrograph showing MT treated
with WCE. D. Graphical representation of comparison showing the percentage of
tubulin present in supernatant fraction after treatment with WCE, wild-type Rev and
M6.

68

A

B

S

P

S

P

(

Tubulin

C

D

69

WCE

wild-type Rev, M6 did not lead tubulin to fractionate into pelleted fractions during
sedimentation assay (student’s t-test; p=0.42) (Figure 17, 18). TEM analysis of M6tubulin mixtures however detected the presence of ringed structures similar to those
formed by wild-type Rev (Figure 10). The sizes of these rings were smaller then those
formed by wild-type Rev (Figure 19). Similar to wild-type Rev, analysis of 1:1 M6tubulin heterodimer mixtures by S200 gel filtration shows that M6 forms high
molecular weight complexes in the presence of Mg++ that elutes out in the void
volume (Figure 8). In contrast to the results obtained with wild-type Rev, the
stoichiometry of tubulin and M6 is altered and more heterogeneous than positive
controls.
In the absence of Mg++, sedimentation assays demonstrates that M6 did not
form high molecular weight complexes in a significant manner (Student’s t-test;
p=0.12) (Figure 18). S200 chromatography however shows that M6 retains the ability
to bind tubulin and forms heterogeneously sized complexes, ranging in size from 150
to 500 kDa (Figure 9). On the contrary, wild-type Rev forms complexes eluting in the
fractions corresponding to ≈142 and 177 kDa.
Measuring interactions between M6 and MTs
The ability of M6 to depolymerize MTs was analyzed by sedimentation assays
where depolymerization was monitored by quantifying the amount of tubulin in the
supernatant fraction. In contrast to wild-type Rev, M6 was unable to depolymerize
MT both in the presence and absence of Mg++ (Student’s t-test; p=0.25 and p=0.34
respectively) (Figure 20). MT in the presence of M6 appeared healthy as compared to
those treated by wild-type Rev, as observed by TEM (Figure 14). MT peels and rings
were rarely seen in presence of M6 showing very little
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Figure 18: Sedimentation Assays of M6 with tubulin. A. Representative coomassie
stained gel showing tubulin mass in the supernatant (S) and pellet fraction (P) when
tubulin heterodimers are incubated with varying concentration of M6, in the presence
of Mg++. B. Graphical representation of the amount of tubulin present in supernatant
(S) fractions after incubation with M6 (coomassie stained gel in A) in the presence of
Mg++. C. Coomassie stained gel showing tubulin concentration in the (S) and (P)
fraction when tubulin heterodimers are incubated with varying concentration of M6,
in the absence of Mg++. D. Graphical representation of the amount of tubulin
heterodimers present in supernatant (S) fractions after incubation with M6 in the
absence

of

Mg++.
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Figure 19: The diameters of RTTs formed by wild-type Rev and M6 are
different. This graph plots the diameter of RTTs formed by wild-type Rev (n=81,
black) or M6 (n=94,red) on the x-axis against the frequency of RTTs with a specific
diameter (y-axis).
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Figure 20: Sedimentation Assays of Rev M6 with MTs. A. Coomasie stained gel
showing tubulin concentration in the supernatant (S) and pellet (P) fraction when
GMPCPP polymerized MT are incubated with varying concentration of Rev M6, in
the presence of Mg++. B. Graphical representation of the quantification of tubulin
heterodimers released in the (S) fraction after incubation with varying concentration
of Rev (coomasie stained gel in A) in the presence of Mg++. C. Coomasie stained gel
showing tubulin concentration in the (S) and (P) fraction when GMPCPP polymerized
MT are incubated with varying concentration of Rev M6, in the absence of Mg++. D.
Graphical representation of the quantification of tubulin heterodimers released in the
(S) fraction after incubation with varying concentration of Rev (coomasie stained gel
in C) in the absence of Mg++.
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sign of MT depolymerization. The occurrence of rings could be the results of M6
interacting with small amount of background tubulin being released from MT
spontaneously, causing ring formation. Interestingly M6 filaments were also observed
in the presence of MTs (Figure 14), suggesting deficiency in liberation of Rev from
M6 filaments.
Taken together, the results demonstrate that deletion of four arginines reduces
the ability of Rev to depolymerize MTs. The deletions also affect ring formation by
M6, as rings formed by M6 are smaller in size compared to those formed by wild-type
Rev.
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DISCUSSION
Rev and filament formation
The long-term goal of this study was to study the mechanism underlying RevMT interactions. Table 2 summarizes the finding of this research. Specifically, one
aim was to determine the role played by Rev-Rev interactions in RTT formation and
MT depolymerization by comparing the ability of the M4 mutant to interact with
tubulin relative to the wild-type protein. The second aim was to test the hypothesis
that the ARM, specifically residues 41-44 altered by the M6 mutation are important
for Rev-MT interactions, specifically involved in tubulin binding. These mutations
were used because they have well-characterized biochemical and biological effects
(Malim et al., 1991; Battiste et al., 1996; Brice et al., 1999) and thus were a good
place to start with Rev-MT studies. When its multimerization motifs are mutated, Rev
lacks the ability to form high order multimers (Malim et al., 1991; Daly et al., 1993,
1995; Auer et al., 1994; Thomas et al., 1998; Brice et al., 1999). In contrast, Rev’s
ARM is not involved in multimerization but is critical for RRE binding and nuclear
import (Daelmans et al., 2004).
This work began with protein purification and its polymerization into
filaments. Although filament formation is known to be the best way to keep Rev
functional in the absence of high salt (Watts et al., 1998), it is not known whether
Rev’s ability to form filaments requires the presence of the ARM and the ability to
multimerize. The results presented here show that wild-type Rev formed filaments
similar in width (≈13 nm) to those described by Watts et al., 1998. In the case of M4,
no such filaments were observed, instead short oligomers were seen. The oligomers
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Table 2: Summary of effect of Rev and its mutants on tubulin heterodimers and
MTs.
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were not straight as filaments formed by wild-type Rev suggesting that there is a
conformational change in the way one M4 interacts with the other. The absence of
filaments showed that mutating residues 23, 25 and 26 in M4 affects Rev’s ability to
multimerize that prevented filament formation. Although it is formally possibly that
M4 is misfolded, other labs have successfully purified functional protein using
comparable methods (e.g., Brice et al., 1999). The result that M4 forms complexes
with tubulin heterodimers with comparable apparent molecular masses to those
formed by wild-type Rev and tubulin suggests that the mutant protein retains the
capacity to bind tubulin.

This is consistent with the observation that M4 has

negligible affects on RRE binding (Brice et al., 1999). These results suggest that the
inability of M4 to multimerize is due to mutation in Rev and does not depend upon
the substrate with which it interacts.
Despite the fact that M6 could not be purified to the same extent as M4 or the
wild-type protein, M6 was successfully refolded into stereotypical filaments despite
the presence of impurities (Figure 5). These results suggest that arginines 41-44
deleted in M6 have a very limited role in filament formation.
TEM analysis shows that purified Rev is in form of distinct filaments and not
aggregated. Results of gel filtration experiments described earlier that show Rev
eluting out with tubulin heterodimers and TEM results showing Rev forming high
molecular weight complexes with tubulin heterodimers also suggests that Rev used
during the experiments is not aggregated.
Interaction between M4 and tubulin/MTs
Watts et al. (2000) previously showed that wild-type Rev protein could bind
and depolymerize microtubules forming RTTs in the process. Their observation that
Rev also forms RTTs when mixed with colchicine-treated heterodimers suggests that

80

the ability to form tubulin rings must lie with Rev since colchicine prevents tubulin
polymerization. Therefore, if Rev is to join two different tubulin heterodimers
together into a ring, then Rev must possess two binding sites. One will mediate the
binding of one Rev monomer to a tubulin monomer present in the first of two adjacent
heterodimers. The second site must then link to the adjacent tubulin heterodimer by
binding either to a tubulin monomer or to a second Rev monomer bound to a tubulin
monomer. The two models are distinguished by requirement of Rev multimerization,
which at the very least must include dimerization.
Use of the M4 mutant affords an opportunity to distinguish between the two
models. It has a well-documented effect on multimerization on the RRE while having
only a small effect on RRE binding (Brice et al., 1999). Moreover, the mutation is
predicted not to interfere with Rev’s ability to bind tubulin because the affected amino
acids (#23, #25 and #26) lie outside the putative tubulin-binding domain. Although
this binding site is not known with certainty, Watts et al. (2000) demonstrated that
this activity likely resides in the N-terminal 59 amino acids and speculated that amino
acids 34-59 are critical owing to a limited amino acid sequence similarity shared with
Kinesin-13 proteins (Watts et al., 2000). Data from both sedimentation assays (Figure
11), and size exclusion chromatography (Figure 8) showing that M4 readily forms
high molecular weight complexes with tubulin (Mr≥500 kDa) are consistent with the
hypothesis that M4 mutation does not perturb tubulin binding. This is also confirmed
by fluorescence immunolocalization (Figure 15). If Rev binding is sufficient to
depolymerize microtubules, then the M4 mutation should not affect microtubule
depolymerization. The observations that the wild-type and not the mutant protein
depolymerizes stabilized microtubules refute this hypothesis (Figures 13 and 16).
Thus, it seems likely that Rev-Rev interactions are as important as Rev-tubulin
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binding events. This is not surprising. It seems unlikely Rev has two separate binding
sites for tubulin given its small size (116 amino acids) and that it is surprising that it
has even one binding site given Rev’s function during HIV infection.
Only a Rev dimer is logically required to link tubulin separate heterodimers
into a RTT. There are several reasons for believing that Rev is acting within an
oligomer larger than a dimer. First, the M4 mutation is not defective in dimerization,
at least on its native target, the RRE (Brice et al., 1999). Instead, the mutation
appears to affect Rev’s ability to form high molecular weight complexes. Second, Rev
has a propensity to form long polymers in the presence and absence of the RRE
(Heaphy et al., 1991; Wingfield et al., 1991; Watts et al., 1998). Moreover, the
estimated dimensions of a Rev monomer suggest it is sufficiently big to span the
surface of a tubulin monomer within an RTT and maintain contact with adjacent Rev
subunits (Wingfield et al., 1991; Watts et al., 1998; Watts et al., 2000). Finally, no
depolymerization was seen at stoichiometries as high as two Rev monomers per
tubulin monomer (Figure 13). It seems likely that a significant number of microtubule
ends would be bound by Rev and some depolymerization detected at this
concentration. This conclusion may be tempered by the possibility that the M4
mutation greatly reduces its affinity for microtubule ends and would thus require
higher M4 concentrations. This seems unlikely given that M4 interacts with tubulin
heterodimers as well as the wild-type protein.
Rev multimerization may facilitate microtubule depolymerization by several
mechanisms. Since Rev depolymerizes microtubules from their ends (Watts et al.,
2000), multimerization along the lattice can increase the rate tubule ends are bound.
In contrast to Kinesin-13s that diffuse across the microtubule lattice (Ogawa et al.,
2004) and kinesin-8s that actively translocate toward the microtubule plus end before
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stimulating depolymerization (Gupta et al., 2006, Varga et al., 2006), multimerization
is a means Rev may target microtubule ends. How relevant this is will depend upon
the extent multimerization is cooperative on the lattice. Indeed, Rev multimerization
on the RRE is partially cooperative (Daly et al., 1993; Zemmel et al., 1996; Van Ryk
and Venkatesan, 1999) and it can form polymers 40-120 nm long at moderate
concentrations (40µg/ml) (Wingfield et al., 1991).
Multimerization may also be important for stabilizing curved tubulin
conformations and/or exerting sufficient force to bend protofilaments. This seems
likely given M4’s inability to form RTTs with colchicine-treated heterodimers.
Multimerization may be important in one of two ways (Figure 21). Multimerization
across the microtubule surface would provide multiple contact sites in which the
forces required to bend a protofilament might be deflected. This is precisely the
mechanism employed by the kinesin-13s that make multiple contacts along the
surface of the protofilament (Moores et al., 2002; Hertzer et al., 2003; Ogawa et al.,
2004, Shipley et al., 2004). In this model, if M4 is altering the conformation of
monomers within a Rev oligomer bound to a MT end, then the number of tubulin sites
productively bound by Rev will decrease. The failure of M4 to depolyermize MTs is
due to the failure to make the Rev oligomer sufficiently rigid to override the
conformation of the intact MT.
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Figure 21: Interaction between MTs and wild-type Rev and M4. A. Wild-type
Rev binds and multimerizes on MT lattice and as it finds free MT ends, Rev
oligomers stabilize the curved conformation of MT ends thus initiating RTTs
formation. B. (i) M4 binds the MT lattice, and (ii) due to conformation change allows
Rev monomers within an oligomer to bind tubulin out of the plane of the original
bound MT (crosslinking), or (iii) alternatively there is no conformation change in M4
that still just forms oligomers, binds the MT lattice like a ‘caterpillar’ and causes
adjacent MT to crosslink with binding site opposite to each other on M4.
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This is supported by the observation that M4 and not the wild-type protein has
a tendency to bundle microtubules. The ability to cross-link microtubules suggests
that the M4 mutation is altering the orientation of Rev monomers with an oligomer
such that MTs lying in a different plane can be bound. This would also explain why
M4 is deficient in multimerization on the RRE. This capacity to generate mechanical
force is reduced in case of M4 because of the lack of ability to form higher order
multimers.
On the other hand it is also a possibility that the ability to multimerize may be
arranging Rev spatially in such a way that MT binding sites are oriented in a manner
to contact tubulin residues that control tubulin structure. Similar spatial arrangement
is seen in case of the neck of MCAK that promotes disruption of lateral interaction
between protofilaments and promotes MCAK diffusion on MT lattice. This ability
being absent in M4 prevents it from depolymerization.
Interaction between M6 and tubulin/MTs
The ARM shares a sequence similarity with the catalytic domain of MCAK and is
proposed to play an important role in MT binding and depolymerization (Watts et al.,
2000). If true, the M6 mutation should reduce tubulin binding, inhibit MT
depolymerization, and block RTT formation.

Indeed, high molecular weight

complexes are not readily detected by sedimentation assays when M6 is mixed with
colchicine-treated tubulin. Because these assays monitor complex formation, they do
not differentiate between the possibilities that M6 affects tubulin binding or the
formation of complexes after tubulin binding. Indeed RTTs are detected by TEM
(Figure 10) albeit ring size is altered (Figure 19) suggesting that the M6 mutation
does not elimination tubulin binding. Smaller ring diameters may be due to more
compact and tighter arrangement of Rev within RTTs possibly increasing the tension
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across the ring and promoting ring instability. The deletion of four positive charged
arginines along with the introduction of one negatively charged aspartic acid and
hydrophobic leucine might affect the conformation of the tubulin binding site. S200
chromatography confirms M6 forms complexes with tubulin and that these complexes
are different from complexes seen with the wild-type protein. M6 complexes in the
presence and absence of Mg++ are smaller and heterogeneously sized (Figures 8 and
9). Taken together, these assays collective suggest that this mutation reduces but not
eliminates tubulin binding and alters complex formation and complex stability.
Surprisingly, the most compelling evidence that the M6 mutation affects
tubulin binding comes from experiments were M6 is mixed with stabilized MTs. In
experiments where Rev filaments are mixed with MT, substantial amounts of Rev
filaments persist. Superficially, this could mean that M6 filaments are more stable
than wild-type filaments and that Rev is unable to dissociate from the filament to
interact with MT. However, because M6 filaments are never seen in the presence of
tubulin heterodimers, this possible explanation is untenable. Thus, it appears that M6
has a reduced affinity for MTs than free tubulin. Because the exposed surface area of
tubulin is reduced when it is in the MT polymer, it seems likely that M6 is capable of
only binding MT ends.
Role of Magnesium in RTT formation
Watts et al. (2000) has shown that Rev forms high molecular complexes with
Rev requires Mg++. Experiments performed here are consistent with these findings.
The role of Mg++ in RTT formation is unclear. Clearly, Mg++ by tubulin for binding
guanine nucleotide. However, if MTs are first polymerized in the presence of Mg++
and then Rev is added but Mg++ concentrations are limiting, then RTTs do not form
suggesting that Mg++ is also required for RTT formation. Although there is little
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additional data to clarify the role of Mg++, Figure 9 (the S200 chromatography-no
Mg++) suggests that the ability to form Rev-tubulin complexes in the absence of Mg++
is relieved by the M6 mutation. Thus, if the M6 mutant is capable of only binding
MT ends, it seems plausible to suggest that Mg++ is important for binding MT lattices.
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FUTURE EXPERIMENTS
Watts et al. (2000) have suggested a limited sequence similarity between
Rev’s ARM and the catalytic domain of MCAK (Figure 2) that extends above and
beyond residues 41-44 mutated in M6. The role of these additional residues in RevMT interactions needs investigation. Earlier experiments characterizing Rev’s
multimerization has also shown involvement of additional residues in Rev
multimerization-1. Analysis of the role of these residues in Rev’s ability to form
RTTs and MT depolymerization will further shed mechanistic insights in Rev-MT
interaction.
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SIGNIFICANCE
Studies conducted by Miyazaki et al. (1995) have shown that expression of
Rev causes Cos7 cells to accumulate in G2/M phase of cell cycle. These effects were
confirmed in HeLa cells and the cell cycle defect was localized to a point prior to the
spindle assembly (N. Smith, personal communication). Moreover, these defects were
also observed following expression of M4 and M6 although the severity of the defects
was reduced (N. Smith, personal communication). Tubulin and Rev or Rev mutants
can be detected in immunopreciptates from whole cell extracts using tubulin- and
Rev-specific antibodies indicating that both proteins physically interact in cells.
Despite this, there is no compelling co-localization between Rev and MT suggesting
that Rev must be interacting with tubulin heterodimers and not MTs (P. Kothalaxmi,
personal communication). Since Rev accumulates perichromosomally during mitosis,
it is spatially localized to inhibit MTs nucleating on the surface of chromatin through
its interaction with heterodimers. This hypothesis is consistent with the results
presented here showing that wild-type Rev, M4 and M6 each interact with
heterodimers but only wild-type Rev is able to depolymerize stabilized MTs.
Rev’s potential to be developed into an anti-MT agent is further reinforced as
HIV infected cells are known to have large-scale MT pathologies. Although, MT
pathologies observed during HIV infection has been attributed to viral protein-gp120
(Malorni et al., 1997), the findings that Rev depolymerizes MTs and causes cell cycle
defects suggests that gp120 may not be solely responsible and that Rev may also be
responsible for these MT pathologies.
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APPENDIX
Appendix A: Primer/oligonucleotide sequence
1) Rev mutant M4 (YSN23,25,26DDL)
Primer sequence:
F5’ CGT CTG ATC AAA TTC CTG GAC CAG GAT CTC CCG CCA CCG AAC CCG 3’
R3’ GCA GAC TAG TTT AAG GAC CTG GTC CTA GAG GGC GGT GGC TTG GGC 5’

2) Rev mutant M6 (RRRR41-44 DL)
Primer sequence :
F5’ CAG GCG CGC CGT AAC GAC CTT TGG CGT GAA CGT CAG 3’
R3’ GTC CGC GCG GCA TTG CTG GAA ACC GCA CTT GCA GTC 5’
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